Navigation Links
Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
Date:9/17/2007

Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and nutraceutical products. The Company's core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms. Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and the London Stock Exchange's Alternative Investment Market (PSG). In March 2006, an ADR - Level 1 program was established in the U.S. with The Bank of New York Mellon (PPGNY) for U.S. investors to trade in Phosphagenics' stock on the 'over-the-counter' market. This has now been upgraded to the International OTCQX, a new premium market tier in the US for international exchange-listed companies, operated by Pink Sheets, LLC.

For more information and to view the clinical trial results in full, please visit Phosphagenics' web site at http://www.phosphagenics.com

Safe Harbor Statement

This press release contains forward-looking statements based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialise, actual results could vary materially from the Phosphagenics' expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations.


'/>"/>
SOURCE Phosphagenics Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
2. Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter
3. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
4. Isotechnikas independent data monitoring committee conducts review of phase 2b kidney transplant trial
5. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... to the medical, research and veterinary markets, announced today ... Officer, will present at the CL King 12 th ... 9, 2014 at 12:30 p.m. ET. The conference will ... New York City . ...
(Date:8/29/2014)... 29, 2014 Research and Markets  has ... Tissue Repair Devices Market 2014-2018" report to their ... mass of cells that connect, support, or surround bones. ... as tendons, ligaments, cartilage, fascia, and other fibrous tissues. ... tissues with age result in wear and tear in ...
(Date:8/28/2014)...  Rigrodsky & Long, P.A.: , Do you, ... LCI )? , Did you purchase your shares before ... 2014, inclusive? , Did you lose money in your ... to discuss your rights? Rigrodsky & ... Timothy J. MacFall , announces that a complaint has been filed ...
Breaking Medicine Technology:Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3
... Regado Biosciences, a privately held company leading the ... that Ellen McDonald, MBA, Senior Vice President and Chief ... at the Pennsylvania Convention Center in Philadelphia, Pennsylvania.  Ms. ... on Wednesday, November 10 in the Life Science Room ...
... a biopharmaceutical company focused on the discovery and development ... and chronic viral diseases, announced today that it has ... Project (QTDP) administered under section 48D of the Internal ... innovative projects that are determined by the U.S. Department ...
Cached Medicine Technology:Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania 2Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania 3
(Date:8/29/2014)... 2014 Floors of hospitals and other ... socks. Also, many patients are relegated to lying down ... recovery, Alzheimer’s, etc. Two inventors from Perrysburg, Ohio, have ... safety. , This special pair of socks helps prevent ... patients who are relegated to beds or chairs from ...
(Date:8/29/2014)... Francisco, CA (PRWEB) August 30, 2014 ... 10 best web conference providers in the online service ... the list were global leaders Webex, GotoMeeting and Infinite. ... the industry users have to determine which provider is ... Essentially, web conference businesses search for compelling consumer goods ...
(Date:8/29/2014)... by volunteering are getting more out of it than ... health boost! , A new study, led ... and published online this week in Psychological Bulletin ... at all the available peer-reviewed evidence regarding the psychosocial ... Lead investigator Dr. Nicole Anderson, together with scientists from ...
(Date:8/29/2014)... 29, 2014 University of Western States ... professionals, announced that Daniel Redwood, DC, director of the ... of the Year,” by the Missouri State Chiropractors Association ... 21. , Patrick Montgomery, DC, president of the MSCA, ... the Missouri House Task Force for Medicaid Reform, in ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Evolutions Medical ... Barbara in the Santa Barbara News-Press Readers’ Choice 2014 ... the Readers’ Choice poll as Best Medical Spa. The ... reads the following about Evolutions Medical Spa recognition: , ... it is recognized as a top-notch, cutting-edge medical spa ...
Breaking Medicine News(10 mins):Health News:Top10InAction Reveals Best Web Conference Providers 2Health News:Evidence mounting that older adults who volunteer are happier, healthier 2Health News:University of Western States Director of Human Nutrition and Functional Medicine Daniel Redwood, DC, named Missouri Educator of the Year by MSCA 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3
... on fatty acids conducted at the universities of Helsinki ... the level of fibrinogen detrimental to health in the ... in essential fats in one,s diet, decreases when saturated ... research results were published in the journal Prostaglandins, ...
... HealthDay Reporter , SUNDAY, Nov. 7 (HealthDay News) ... the joints, new research suggests. The autoimmune disorder ... plaque in the blood vessels, potentially increasing the risk of ... news from the study is that certain drugs already used ...
... new study suggests joint complaints attributed to aromatase inhibitors ... inflammatory arthritis or autoimmune disease. Because of that, ... threat of arthritis should be encouraged to continue taking ... presented Tuesday, Nov. 9 at the 74th Annual Scientific ...
... , SUNDAY, Nov. 7 (HealthDay News) -- People suffering from ... taking vitamin D supplements, U.S. researchers report. "I,ve never ... Kevin Dalal, an assistant professor of rehabilitation medicine at the ... surprised it didn,t work. It,s a tough process to try ...
... hospitalised with severe malaria has concluded that the drug ... disease in both children and adults everywhere in the ... published today online in the journal The Lancet ... Professor Nick White of the Wellcome Trust-Mahidol University-Oxford Tropical ...
... 5 (HealthDay News) -- Falls from tree stands are the ... University study. Researchers analyzed 130 hunting-related trauma admissions at ... percent of injuries were caused by falls, and 92 percent ... other findings: , Gunshot wounds accounted for 29 percent ...
Cached Medicine News:Health News:Canola-type rapeseed oil reduces the level of fibrinogen, a cause of thrombosis and inflammation 2Health News:Rheumatoid Arthritis May Raise Risk of Blood Vessel Plaque 2Health News:Rheumatoid Arthritis May Raise Risk of Blood Vessel Plaque 3Health News:Joint pain linked to breast cancer drug not inflammatory arthritis or autoimmune disease 2Health News:Vitamin D No Magic Bullet for Osteoarthritis 2Health News:Major clinical trial prompts call for change to treatment guidelines for severe malaria worldwide 2Health News:Major clinical trial prompts call for change to treatment guidelines for severe malaria worldwide 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: